ORIG3N, a leader in regenerative medicine technology and consumer genetics assessments, has unveiled two new DNA tests focused exclusively on individuals' future development. The Company's DNA tests are designed to reveal genetic information that will remove some of the roadblocks along the path to optimal health. This will ease the frustration consumers often feel when identifying what will work best for their unique sensitivities, behavioral factors and more.

With ORIG3N's DNA tests customers can confirm things they always suspected about themselves, and discover things they never knew. 

Boston, US
Size (employees)
48 (est)-7%
Orig3n was founded in 2014 and is headquartered in Boston, US
Report incorrect company information

Orig3n Office Locations

Orig3n has an office in Boston
Show all (1)
Report incorrect company information

Orig3n Financials and Metrics

Summary Metrics

Orig3n's latest funding round in July 2018 was reported to be $14.4 m. In total, Orig3n has raised $50 m
Show all financial metrics
Report incorrect company information

Orig3n Online and Social Media Presence

Embed Graph
Report incorrect company information

Orig3n News and Updates

Orig3n Founders Named Finalists for Ernest and Young Entrepreneur Of The Year® 2018 Award

BOSTON, June 22, 2018 /PRNewswire/ -- Orig3n, a Boston-based biotech company pioneering the future of health through genetics and regenerative medicine, today announced that its co-founders, Robin Y. Smith, CEO, and Kate Blanchard, COO, are finalists for the Ernest and Young Entrepreneur...
Report incorrect company information

Orig3n Company Life and Culture

Report incorrect company information